About the call

Monoclonal antibodies (mAbs) are one of the most powerful tools in modern medicine, offering a highly specific and effective treatment for a range of conditions – from infectious diseases to chronic illnesses.   

These biologic therapies can provide life-saving targeted interventions and improve the quality- of-life for millions of patients globally. Yet, the high production costs associated with mAbs limit access to these vital treatments for patients in low- and middle-income settings. 

mAb costs have decreased significantly in the last 30 years but have plateaued at ~ $50–100 per gram. To make these life-saving treatments accessible in low- and middle-income countries, we must achieve a breakthrough: reducing the final drug substance cost-of-goods to $10 per gram.  

We are calling on innovators, scientists, engineers, and entrepreneurs- from seasoned experts in biologics to pioneers in related fields- to join us in our ambition to develop manufacturing platforms that produce monoclonal antibodies at a final drug substance cost-of-goods of $10 per gram.  

This is more than a technical challenge; it is a chance to transform millions of lives across the globe. We invite you to bring your expertise, creativity, and passion to this cause. Let’s work together to shape a future where the best medical treatments are available to everyone, everywhere.